Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study-Reference-Cited by-同舟云学术

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study

Published:2009-03 Issue:6 Volume:100 Page:888-893
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Berney D M, ,Gopalan A,Kudahetti S,Fisher G,Ambroisine L,Foster C S,Reuter V,Eastham J,Moller H,Kattan M W,Gerald W,Cooper C,Scardino P,Cuzick J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6604951.pdf

Reference27 articles.

1. Albertsen PC, Hanley JA, Fine J (2005) 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293: 2095–2101

2. Attard G, Clark J, Ambroisine L, Fisher G, Kovacs G, Flohr P, Berney D, Foster CS, Fletcher A, Gerald WL, Moller H, Reuter V, De Bono JS, Scardino P, Cuzick J, Cooper CS (2008) Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene 27: 253–263

3. Bettencourt MC, Bauer JJ, Sesterhenn IA, Mostofi FK, McLeod DG, Moul JW (1996) Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy. J Urol 156: 1064–1068

4. Bott SR, Freeman AA, Stenning S, Cohen J, Parkinson MC (2005) Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time. BJU Int 95: 34–39

5. Clark J, Attard G, Jhavar S, Flohr P, Reid A, De-Bono J, Eeles R, Scardino P, Cuzick J, Fisher G, Parker MD, Foster CS, Berney D, Kovacs G, Cooper CS (2008) Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene 27: 1993–2003

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Digital analysis of the prostate tumor microenvironment with high-order chromogenic multiplexing;Journal of Pathology Informatics;2024-12

2. Neoadjuvant Exercise Therapy in Prostate Cancer;JAMA Oncology;2024-07-18

3. Clinical Characteristics and Prognostic Markers of Aggressive Subtypes of Thyroid Cancer: A Retrospective Chart Review Study;2024-03-21

4. Assessment of Ki-67 expression in cases of prostatic carcinoma and its correlation with clinical outcomes;Indian Journal of Pathology and Microbiology;2024-02-14

5. Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts;World Journal of Clinical Cases;2024-01-06